BioCLIA Autoimmune Reagent Kit, β2 Glycoprotein 1 Screen

Primary DI

06924030415761

Basic UDI-DI Code

B-06924030415761

Reference

MY00127C

Device Types

None provided

Regulation

Eu Ivdd

Classification

Eu Ivd General

Status

On The Market

Manufacturer

HOB Biotech Group Corp., Ltd.

The BioCLIA Autoimmune Reagent Kit, β2 Glycoprotein 1 Screen assay is intended for the in vitro semi-quantitative measurement of anti- β2 Glycoprotein 1 IgA/IgG/IgM antibodies in human serum and plasma as an aid in the diagnosis of primary Antiphospholipid Syndrome (APS) and those secondary to systemic lupus erythematosus (SLE) or SLE-like disorders in conjunction with other laboratory and clinical findings. It is an in vitro diagnostic medical device intended for laboratory professional use. The BioCLIA Autoimmune Calibrator Set, β2 Glycoprotein 1 Screen is intended for the calibration of the BioCLIA β2 Glycoprotein 1 Screen performed on the BioCLIA 6500 and BioCLIA 500. The BioCLIA Autoimmune Control Set, β2 Glycoprotein 1 Screen is intended for the quality control purposes of the BioCLIA β2 Glycoprotein 1 Screen performed on the BioCLIA 6500 and BioCLIA 500. For professional in vitro diagnostic use only.

Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).